Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Coya Therapeutics (COYA.US)$ Reuters· 4 mins ago
Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (Ld Il-2) + Ctla4-Ig Fusion Protein in Patients With Frontotemporal Dementia (Ftd)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
1048 Views
Comment
Sign in to post a comment